Kethakie Lamahewa 1 , Marta Buszewicz 1 , Kate Walters 1 , Louise Marston 1 , Irwin Nazareth 1 . Show Affiliations »
Abstract
BACKGROUND: Unexplained physical symptoms (UPS) are extremely common among primary care attenders, but little is known about their longer-term outcome. AIM: To investigate the persistence of somatic symptoms at 6 months among a cohort with multiple UPS, and identify prognostic factors associated with worsening symptom scores. DESIGN AND SETTING: Prospective longitudinal cohort study involving adults attending UK general practice in North and Central London between January and December 2013. METHOD: Consecutive adults attending nine general practices were screened to identify those with at least three UPS. Eligible participants completed measures of symptom severity (measured using the Patient Health Questionnaire Somatic Symptom Module [PHQ-15]), physical and mental wellbeing, and past health and social history, and were followed up after 6 months. Multivariable linear regression analysis was conducted to identify prognostic factors associated with the primary outcome: somatic symptom severity. RESULTS: Overall, 245/294 (83%) provided 6-month outcome data. Of these, 135/245 (55%) reported still having UPS, 103/245 (42%) had symptoms still under investigation, and only 26/245 (11%) reported complete symptom resolution. Being female, higher baseline somatic symptom severity, poorer physical functioning, experience of childhood physical abuse, and perception of poor financial wellbeing were significantly associated with higher somatic symptom severity scores at 6 months. CONCLUSION: This study has shown that at 6 months few participants had complete resolution of unexplained somatic symptoms. GPs should be made aware of the likelihood of UPS persisting, and the factors that make this more likely, to inform decision making and care planning. There is a need to develop prognostic tools that can predict the risk of poor outcomes. © British Journal of General Practice 2019.
BACKGROUND: Unexplained physical symptoms (UPS) are extremely common among primary care attenders, but little is known about their longer-term outcome. AIM: To investigate the persistence of somatic symptoms at 6 months among a cohort with multiple UPS, and identify prognostic factors associated with worsening symptom scores. DESIGN AND SETTING: Prospective longitudinal cohort study involving adults attending UK general practice in North and Central London between January and December 2013. METHOD: Consecutive adults attending nine general practices were screened to identify those with at least three UPS. Eligible participants completed measures of symptom severity (measured using the Patient Health Questionnaire Somatic Symptom Module [PHQ-15]), physical and mental wellbeing, and past health and social history, and were followed up after 6 months. Multivariable linear regression analysis was conducted to identify prognostic factors associated with the primary outcome: somatic symptom severity. RESULTS: Overall, 245/294 (83%) provided 6-month outcome data. Of these, 135/245 (55%) reported still having UPS, 103/245 (42%) had symptoms still under investigation, and only 26/245 (11%) reported complete symptom resolution. Being female, higher baseline somatic symptom severity, poorer physical functioning, experience of childhood physical abuse, and perception of poor financial wellbeing were significantly associated with higher somatic symptom severity scores at 6 months. CONCLUSION: This study has shown that at 6 months few participants had complete resolution of unexplained somatic symptoms. GPs should be made aware of the likelihood of UPS persisting, and the factors that make this more likely, to inform decision making and care planning. There is a need to develop prognostic tools that can predict the risk of poor outcomes. © British Journal of General Practice 2019.
Entities: Species
Keywords:
general practice; primary health care; somatic symptoms; unexplained physical symptoms
Mesh: See more »
Year: 2019
PMID: 30692088 PMCID: PMC6428483 DOI: 10.3399/bjgp19X701249
Source DB: PubMed Journal: Br J Gen Pract ISSN: 0960-1643 Impact factor: 5.386